Patrick Radden Keefe · 2021

Empire of Pain

The Secret History of the Sackler Dynasty

Rough AI truth score

83/100

The documentary record strongly supports Purdue's deceptive promotion and the Sackler family's financial and governance role. OxyContin was a major catalyst, but the opioid epidemic cannot be reduced to one family or company.

Based on three central claims · high confidence

The three claims

01Supported

Purdue Pharma aggressively marketed OxyContin while misleading clinicians and the public about addiction and abuse risks.

Federal criminal cases and unsealed company records document misbranding, sales incentives, high-prescriber targeting, and representations that downplayed risk. Purdue and executives entered guilty pleas in 2007, and the company pleaded guilty again in 2020.

U.S. Department of Justice: United States v. Purdue Pharma DOJ: Purdue Pharma settlement agreement

02Supported

Members of the Sackler family owned Purdue, profited enormously, and exercised meaningful influence over the company's strategy.

Corporate, litigation, congressional, and bankruptcy records establish family ownership, board participation, large distributions, and involvement in growth strategy. Responsibility varied among individuals, so evidence should not flatten every family member into one role.

House hearing: The Sackler Act and Other Policies New England Journal of Medicine: Purdue Pharma settlement

03Mixed

The Sacklers and OxyContin caused the American opioid epidemic.

Purdue's promotion materially expanded high-dose opioid use and helped normalize risky prescribing, making it an important catalyst. The epidemic also involved other manufacturers, distributors, clinicians, regulators, economic distress, heroin, and illicit fentanyl.

Lessons from Corporate Influence in the Opioid Epidemic U.S. Department of Justice: United States v. Purdue Pharma

Other claims worth checking

Philanthropic naming helped build social prestige while obscuring the source of family wealth.
Bankruptcy law became a central arena for negotiating corporate and family accountability.

What this number means. It is an AI-generated first-pass judgment of three central factual or causal claims—not a rating, exhaustive fact-check, or human peer review. Claim credits are 100% for supported, 75% for mostly supported, 50% for mixed, and 25% for weak, then averaged and rounded. Lower confidence means the score should move more as better evidence arrives.

Method three-central-claims/0.1.0 · checked 2026-09-01 · 3/3 selected claims assessed · method and source audit